Where does Bios SRL rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bios SRL ranks #25,882 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bios SRL hold?

Bios SRL holds 10 US utility patents granted between 2017 and 2025, spanning 7 technology areas.

What is Bios SRL's Innovation Score?

Bios SRL has an Innovation Score of 35.9 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bios SRL focus on?

Bios SRL's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 6 patents, ranking #583 of 1,943 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Bios SRL's patent grant rate increasing or decreasing?

Bios SRL's recent grant velocity is +700% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Bios SRL's patents?

Bios SRL's patents average 11.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bios SRL patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bios SRL

USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bios ranks #25,882 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.

#25,882
of 49,997 US assignees by volume: Top 48%
by Innovation Score (35.9/100): 11.9
avg claims per patent: +700%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25882 · Foreign Corporation #25,882 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #25,882/49,997
PHOTO-FINISH Bielomatic Leuze + KG
CPC-NARROW A61N · 7 areas
INNOV-THIN 35.9/100
CLAIMS-PAR 11.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +700% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bielomatic Leuze GMBH + Co KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bios’s 35.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (23%) Velocity 11.1 pts (31%) Breadth 9.4 pts (26%) Claim depth 7.1 pts (20%)

Qualcomm Incorporated · highest

85
Bios SRL · this assignee

36
3D Lighting… · lowest

7

What this shows Bios's Innovation Score is 35.9/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bios?

Each dot is one of Bios’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bios’s own 11.9 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Bios vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bios's grants concentrate

Bios SRL is a focused PatentsView assignee: 7 CPC subclasses with 60% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2017. By volume, Bios sits between Bielomatic Leuze GMBH + Co KG and Bizerba GMBH & Co. KG.

Bios's three-year grant acceleration

Bios SRL shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bielomatic Leuze…

10
Biodesy

10
Biointellisense

10
Bioleaders

10
Biosearch

10
Biovest Internati…

10
Birko

10
Bizerba & KG

10
Bios SRL ◀

10

What this shows Bios holds 10 patents at rank #25,858, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bios

By rank, the assignees closest to #25,858 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Bios's primary technology class.

Bios's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Bios SRL patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	10.0%
2020	1	10.0%
2021	2	20.0%
2022	2	20.0%
2023	2	20.0%
2024	1	10.0%
2025partial year	1	10.0%

Which technologies does Bios SRL patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

A61B - DIAGNOSIS; SURGERY; Identification 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

H01S - Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges Other Than Optical 1

H01J - Electric Discharge Tubes OR Discharge Lamps 1

G02B - Optical Elements, Systems OR Apparatus 1

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bios SRL's patent record in context - here's where to go next.

Bios SRL's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 60% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #25,882 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bios SRL against Bielomatic Leuze GMBH + Co KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.